Insider Transactions in Q1 2020 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
SELL
Payment of exercise price or tax liability
|
Direct |
33,321
-5.0%
|
$1,899,297
$57.93 P/Share
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
BUY
Other acquisition or disposition
|
Direct |
7,075
+1.7%
|
-
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
BUY
Exercise of conversion of derivative security
|
Direct |
71,868
+9.42%
|
-
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
SELL
Other acquisition or disposition
|
Direct |
397
-0.19%
|
-
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
BUY
Bona fide gift
|
Indirect |
300,000
+50.0%
|
-
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
SELL
Bona fide gift
|
Direct |
300,000
-76.47%
|
-
|
|
Mar 10
2020
|
Christopher S. Boerner Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,167
-12.62%
|
$693,519
$57.83 P/Share
|
|
Mar 10
2020
|
Christopher S. Boerner Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
2,497
+3.87%
|
-
|
|
Mar 10
2020
|
Christopher S. Boerner Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,426
+18.18%
|
-
|
|
Mar 10
2020
|
Christopher S. Boerner Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
109
-0.44%
|
-
|
|
Mar 10
2020
|
Giovanni Caforio Executive Chair of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
116,943
-4.78%
|
$6,665,751
$57.93 P/Share
|
|
Mar 10
2020
|
Giovanni Caforio Executive Chair of the Board |
BUY
Other acquisition or disposition
|
Direct |
20,877
+1.38%
|
-
|
|
Mar 10
2020
|
Giovanni Caforio Executive Chair of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
211,796
+7.71%
|
-
|
|
Mar 10
2020
|
Giovanni Caforio Executive Chair of the Board |
SELL
Other acquisition or disposition
|
Direct |
1,190
-0.15%
|
-
|
|
Mar 10
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,005
-2.14%
|
$114,285
$57.93 P/Share
|
|
Mar 10
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
BUY
Other acquisition or disposition
|
Direct |
561
+0.98%
|
-
|
|
Mar 10
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,007
+4.98%
|
-
|
|
Mar 10
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Other acquisition or disposition
|
Direct |
26
-0.08%
|
-
|
|
Mar 10
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
635
-4.88%
|
$36,195
$57.93 P/Share
|
|
Mar 10
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Other acquisition or disposition
|
Direct |
212
+3.0%
|
-
|
|
Mar 10
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
1,571
+10.98%
|
-
|
|
Mar 10
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Other acquisition or disposition
|
Direct |
30
-0.5%
|
-
|
|
Mar 10
2020
|
John E Elicker EVP, Investor Relations |
SELL
Payment of exercise price or tax liability
|
Direct |
7,860
-2.2%
|
$448,020
$57.93 P/Share
|
|
Mar 10
2020
|
John E Elicker EVP, Investor Relations |
BUY
Other acquisition or disposition
|
Direct |
1,835
+0.85%
|
-
|
|
Mar 10
2020
|
John E Elicker EVP, Investor Relations |
BUY
Exercise of conversion of derivative security
|
Direct |
18,407
+4.83%
|
-
|
|
Mar 10
2020
|
John E Elicker EVP, Investor Relations |
SELL
Other acquisition or disposition
|
Direct |
102
-0.08%
|
-
|
|
Mar 10
2020
|
Sandra Leung EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
28,312
-0.98%
|
$1,613,784
$57.93 P/Share
|
|
Mar 10
2020
|
Sandra Leung EVP, General Counsel |
BUY
Other acquisition or disposition
|
Direct |
5,096
+0.29%
|
-
|
|
Mar 10
2020
|
Sandra Leung EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
51,598
+1.74%
|
-
|
|
Mar 10
2020
|
Sandra Leung EVP, General Counsel |
SELL
Other acquisition or disposition
|
Direct |
298
-0.03%
|
-
|
|
Mar 10
2020
|
Ann Powell EVP, Chief Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
14,462
-5.89%
|
$824,334
$57.93 P/Share
|
|
Mar 10
2020
|
Ann Powell EVP, Chief Human Resources |
BUY
Other acquisition or disposition
|
Direct |
3,093
+2.0%
|
-
|
|
Mar 10
2020
|
Ann Powell EVP, Chief Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
31,169
+10.91%
|
-
|
|
Mar 10
2020
|
Ann Powell EVP, Chief Human Resources |
SELL
Other acquisition or disposition
|
Direct |
174
-0.23%
|
-
|
|
Mar 10
2020
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,017
-6.66%
|
$114,969
$57.93 P/Share
|
|
Mar 10
2020
|
Karen Murphy Santiago SVP & Controller |
BUY
Other acquisition or disposition
|
Direct |
552
+2.78%
|
-
|
|
Mar 10
2020
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
5,063
+14.29%
|
-
|
|
Mar 10
2020
|
Karen Murphy Santiago SVP & Controller |
SELL
Other acquisition or disposition
|
Direct |
39
-0.43%
|
-
|
|
Mar 10
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Payment of exercise price or tax liability
|
Direct |
13,540
-5.42%
|
$771,780
$57.93 P/Share
|
|
Mar 10
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
BUY
Other acquisition or disposition
|
Direct |
3,019
+1.95%
|
-
|
|
Mar 10
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
BUY
Exercise of conversion of derivative security
|
Direct |
30,519
+10.77%
|
-
|
|
Mar 10
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Other acquisition or disposition
|
Direct |
184
-0.24%
|
-
|
|
Mar 10
2020
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,738
-1.45%
|
$612,066
$57.93 P/Share
|
|
Mar 10
2020
|
Paul Von Autenried EVP, Chief Information Officer |
BUY
Other acquisition or disposition
|
Direct |
2,030
+0.45%
|
-
|
|
Mar 10
2020
|
Paul Von Autenried EVP, Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,806
+2.7%
|
-
|
|
Mar 10
2020
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Other acquisition or disposition
|
Direct |
124
-0.04%
|
-
|
|
Mar 04
2020
|
John E Elicker EVP, Investor Relations |
SELL
Open market or private sale
|
Direct |
15,805
-21.22%
|
$964,105
$61.01 P/Share
|
|
Mar 02
2020
|
Rupert Vessey EVP & President, Research |
SELL
Open market or private sale
|
Direct |
84,308
-63.56%
|
$5,058,480
$60.59 P/Share
|
|
Mar 02
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
93,468
+14.46%
|
$4,486,464
$48.03 P/Share
|
|
Mar 01
2020
|
Nadim Ahmed EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct |
8,473
-25.65%
|
$499,907
$59.06 P/Share
|